Vera Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: Aug 5, 2025
BRISBANE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today reported its business highlights and financial results for the second quarter ended June 30, 2025.
Read more at globenewswire.com
